Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2022-01-14
Original market date: See footnote 1
2009-11-23
Product name:
ANAPEN JUNIOR
Description:
SINGLE USE
DIN:
02306743
Product Monograph/Veterinary Labelling:
Date:
2022-01-14
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ENDO OPERATIONS LTD.
1st Floor, Minerva House, Simmonscourt Road
Ballsbridge
Dublin
Ireland
D04 H9P8
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
12:12.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
C01CA24 EPINEPHRINE
Active ingredient group (AIG) number:See footnote5
0104871011
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| EPINEPHRINE | 0.15 MG / 0.3 ML |